These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22791274)

  • 1. Interaction between ciclopirox and acenocoumarol.
    Morales-Molina JA; Pérez-Moyano R; Fayet-Pérez A; Urquízar-Rodríguez O; Gíménez-López MJ
    Eur J Clin Pharmacol; 2013 Mar; 69(3):727-8. PubMed ID: 22791274
    [No Abstract]   [Full Text] [Related]  

  • 2. Miconazole and oral anticoagulants: bleeding.
    Prescrire Int; 2015 Jan; 24(156):19. PubMed ID: 25729827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and weighting of the most critical "real-life" drug-drug interactions with acenocoumarol in a tertiary care hospital.
    Gschwind L; Rollason V; Lovis C; Boehlen F; Bonnabry P; Dayer P; Desmeules JA
    Eur J Clin Pharmacol; 2013 Mar; 69(3):617-27. PubMed ID: 22903542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between amorolfine and acenocoumarol.
    Morales-Molina JA; Fayet-Pérez A; Martínez-Plata E; Pérez-Moyano R; Molina-Arrebola MA
    Eur J Clin Pharmacol; 2012 Dec; 68(12):1687-8. PubMed ID: 22648278
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon.
    Beinema M; Brouwers JR; Schalekamp T; Wilffert B
    Thromb Haemost; 2008 Dec; 100(6):1052-7. PubMed ID: 19132230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laryngeal dyspnea in relation to an interaction between acenocoumarol and topical econazole lotion.
    Wey PF; Petitjeans F; Lions C; Ould-Ahmed M; Escarment J
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):173-7. PubMed ID: 18775393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergic contact dermatitis from ciclopirox olamine.
    Foti C; Diaferio A; Bonamonte D
    Australas J Dermatol; 2001 May; 42(2):145. PubMed ID: 11309043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miconazole-warfarin interaction: increased INR.
    Murty M
    CMAJ; 2001 Jul; 165(1):81-2, 85-6. PubMed ID: 11468962
    [No Abstract]   [Full Text] [Related]  

  • 9. Genotype-guided therapy improves initial acenocoumarol dosing. Results from a prospective randomised study.
    Cerezo-Manchado JJ; Roldán V; Corral J; Rosafalco M; Antón AI; Padilla J; Vicente V; González-Conejero R
    Thromb Haemost; 2016 Jan; 115(1):117-25. PubMed ID: 26538428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition from acenocoumarol to warfarin in a 12-year-old child.
    Hakacova N; Björkhem G; Hanséus K
    Congenit Heart Dis; 2011; 6(6):661-4. PubMed ID: 21501391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of dabigatran versus acenocoumarol in 'real-world' patients with atrial fibrillation.
    Korenstra J; Wijtvliet EP; Veeger NJ; Geluk CA; Bartels GL; Posma JL; Piersma-Wichers M; Van Gelder IC; Rienstra M; Tieleman RG
    Europace; 2016 Sep; 18(9):1319-27. PubMed ID: 26843571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatment.
    Gschwind L; Rollason V; Boehlen F; Rebsamen M; Combescure C; Grünenwald M; Matthey A; Bonnabry P; Dayer P; Desmeules JA
    Pharmacogenomics; 2013 May; 14(7):745-53. PubMed ID: 23651023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in anticoagulant effect of warfarin in a patient using econazole cream.
    Lang PG; LeClercq AH
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S117-9. PubMed ID: 17052529
    [No Abstract]   [Full Text] [Related]  

  • 14. Laboratory techniques alternative to in vivo experiments for studying the liberation, penetration and fungicidal action of topical antimycotic agents in the skin, including ciclopiroxolamine.
    Dittmar W; Jović N
    Mykosen; 1987 Jul; 30(7):326-42. PubMed ID: 3657856
    [No Abstract]   [Full Text] [Related]  

  • 15. Self-control of long-term oral anticoagulation using a point-of-care device.
    Roudaut R
    Arch Cardiovasc Dis; 2008; 101(11-12):683-4. PubMed ID: 19059561
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of acenocoumarol and levofloxacin interaction in elderly institutionalized patients.
    Taberner-Bonastre P; Moreno-Miralles A; Quintana-Vargas I; Peris-Martí JF
    Farm Hosp; 2019 Mar; 43(2):53-55. PubMed ID: 30848177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct oral anticoagulants (DOACs).
    Vazquez S; Rondina MT
    Vasc Med; 2015 Dec; 20(6):575-7. PubMed ID: 26285587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miconazole buccal gel and risk for systemic bleeding: how certain topical formula can interfere with anticoagulants.
    De Pauw A; De Backer T
    Acta Clin Belg; 2015 Apr; 70(2):121-3. PubMed ID: 25331621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
    Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
    Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between warfarin and oral terbinafine. Systematic review of interaction profile of warfarin is needed.
    Clarke MF; Boardman HS
    BMJ; 1998 Jul; 317(7152):205-6. PubMed ID: 9705640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.